Slideshow

Methamphetamine-associated PAH: First Prospective Cohort Study

Methamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.

“The focus on opioids overshadows another worsening drug plague,” read the title of an article in The Economist in June 2017.1 The encroaching plague is the resurgence of methamphetamine abuse that appears to have begun in western states in the US and is moving eastward, particularly affecting rural areas.A recent study in the American Journal of Respiratory and Critical Care Medicine looked at one specific outcome of Meth abuse – Meth-associated pulmonary arterial hypertension (Meth-PAH), a severe, progressive form of PAH, with worse prognosis than idiopathic PAH (IPAH).This short slide show highglights the study and the results.Image on all slides ©style-photography/Shutterstock.com

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.